European Research Initiative on CLL

  • 25/05/2016 2nd International Conference on New Concepts in B-Cell Malignancies
  • 25/05/2016 Certificate of Competence in Lymphoma (CCL3)
  • 22/02/2016 LATEST NEWS at the ERIC Board and Office
  • 25/01/2016 DEADLINE - ASH (American Society of Hematology) abstract submission deadline - 4 August!
  • 19/01/2016 NEW: CLL stereotyped subsets can be recognised reliably online!
View All

ERIC

ERIC is a European organization devoted to improving the outcome of patients with chronic lymphocytic leukemia (CLL) and related diseases.

There are many more open questions and new drugs available for the treatment of CLL than there are study groups or active protocols. To achieve faster progress, open communication between study groups, physicians and scientists is essential.

ERIC is a Working Party of the European LeukemiaNet and a Scientific Working Group of the European Hematology Association. ERIC is open to all physicians and scientists working or interested in the field of chronic lymphocytic leukemia and related disorders.